Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation
- PMID: 15021894
- DOI: 10.1038/sj.onc.1207412
Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation
Abstract
The transforming growth factor-beta (TGFbeta) superfamily controls a plethora of biological responses, and alterations in its signalling pathway are associated with a range of human diseases, including cancer. TGFbeta superfamily ligands signal through a heteromeric complex of Ser/Thr kinase receptors that propagate the signal to the Smad family of intracellular proteins. The ubiquitin-mediated proteasomal degradation pathway is an evolutionary conserved cascade that tightly regulates TGFbeta superfamily signalling. Both the size of the Smad pool in unstimulated cells and Smad protein levels subsequent to the activation of the pathway are controlled by ubiquitination. E3 ligases are components of the ubiquitin-degradation complex that specifically recognize targeted proteins and the E3 ligases, Smad ubiquitination-related factor 1 (Smurf1), Smurf2 and SCF/Roc1 have been implicated in Smad degradation. The Smurfs are of particular importance to TGFbeta signalling, as Smads also function as adapters that recruit the Smurfs to various pathway components including the TGFbeta receptor complex and the transcriptional repressor, SnoN, and thereby regulate the degradation of these Smad-associating proteins. Thus, by controlling the level of Smads as well as positive and negative regulators of the pathway, Smurfs provide for complex and fine control of signalling output. Finally, growing evidence demonstrates that ubiquitination and proteasomal degradation is also implicated in the turnover of tumor-derived Smad mutants and may thus contribute to disease progression.
Similar articles
-
Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice.Int J Dev Biol. 2000 Apr;44(3):253-65. Int J Dev Biol. 2000. PMID: 10853822 Review.
-
RNF11 is a multifunctional modulator of growth factor receptor signalling and transcriptional regulation.Eur J Cancer. 2005 Nov;41(16):2549-60. doi: 10.1016/j.ejca.2005.08.020. Epub 2005 Oct 13. Eur J Cancer. 2005. PMID: 16226459 Review.
-
The smad proteins and TGFbeta signalling: uncovering a pathway critical in cancer.Pathology. 2001 Feb;33(1):73-84. Pathology. 2001. PMID: 11280614 Review.
-
Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.Arthritis Rheum. 2004 Dec;50(12):4008-21. doi: 10.1002/art.20658. Arthritis Rheum. 2004. PMID: 15593186
-
A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation.Nature. 1999 Aug 12;400(6745):687-93. doi: 10.1038/23293. Nature. 1999. PMID: 10458166
Cited by
-
Knocking out USP7 attenuates cardiac fibrosis and endothelial-to-mesenchymal transition by destabilizing SMAD3 in mice with heart failure with preserved ejection fraction.Theranostics. 2024 Sep 9;14(15):5793-5808. doi: 10.7150/thno.97767. eCollection 2024. Theranostics. 2024. PMID: 39346543 Free PMC article.
-
Citronellal improves endothelial dysfunction by affecting the stability of the GCH1 protein.Acta Biochim Biophys Sin (Shanghai). 2024 Jun 3;56(7):963-972. doi: 10.3724/abbs.2024086. Acta Biochim Biophys Sin (Shanghai). 2024. PMID: 38993132 Free PMC article.
-
Cell signaling and transcriptional regulation of osteoblast lineage commitment, differentiation, bone formation, and homeostasis.Cell Discov. 2024 Jul 2;10(1):71. doi: 10.1038/s41421-024-00689-6. Cell Discov. 2024. PMID: 38956429 Free PMC article. Review.
-
The E3 ubiquitin-protein ligase UHRF1 promotes adipogenesis and limits fibrosis by suppressing GPNMB-mediated TGF-β signaling.Sci Rep. 2024 May 24;14(1):11886. doi: 10.1038/s41598-024-62508-y. Sci Rep. 2024. PMID: 38789534 Free PMC article.
-
Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective.Pharmaceuticals (Basel). 2024 Apr 20;17(4):533. doi: 10.3390/ph17040533. Pharmaceuticals (Basel). 2024. PMID: 38675493 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
